Long-term effect of antiviral therapy for grade II cervical intraepithelial neoplasia
Ol’ga P. Vinogradova , Natal’ya A. Andreeva , Ol’ga V. Epifanova , Ol’ga I. Artemova
V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2022, Vol. 9 ›› Issue (4) : 239 -246.
Long-term effect of antiviral therapy for grade II cervical intraepithelial neoplasia
BACKGROUND: The production of many molecular markers at different grades of cervical intraepithelial neoplasia is currently being studied to predict the outcome of the disease and build an individual prognosis. However, no clear criteria for the course of neoplasia are available at this time.
AIM: This study aimed to assess the efficiency of the antiviral immunomodulator Allokin-alpha (Alloferon) in the treatment of cervical intraepithelial neoplasia of moderate severity from the perspective of long-term follow-up.
DESIGN: Prospective study.
MATERIALS AND METHODS: We examined 86 women of reproductive age with grade II cervical intraepithelial neoplasia (CIN II) associated with human papillomavirus (HPV). In the CIN II group, all patients underwent excision of the affected area. According to the study design, 43 women were followed up after excision (Group 1a), while 43 participants were treated surgically and used the study drug (Group 1b). By cytological and colposcopic examination, the efficiency of the chosen therapy was assessed after 3, 12, and 18 months. However, the main criteria for the efficiency of treatment were the absence of HPV or a decrease in the viral load below significant values and the absence of recurrence of the pathological process.
RESULTS: The combination of excision and the use of Allokin-alpha (Alloferon) showed significant advantages over monosurgical treatment.
CONCLUSIONS: The data obtained indicate high HPV elimination and reduced probability of recurrence after excisional treatment in patients with CIN II when using Allokin-alpha (Alloferon).
cervical intraepithelial neoplasia / cervical cancer / human papillomavirus / high oncogenic risk / viral load
| [1] |
Trushina OI, Novikova EG, Shipulina OYu, Romanyuk TN. Viral load of HPV DNA as a prognostic factor of malignant progression of papillomavirus infection. Proceedings of the VIII All-Russian Scientific and Practical Conference with international participation «Molekulyarnaya diagnostika ― 2014» / Ed. by V.I. Pokrovsky. Moscow; 2014;1:207. (In Russ). |
| [2] |
Трушина О.И., Новикова Е.Г., Шипулина О.Ю., Романюк Т.Н. Вирусная нагрузка ДНК ВПЧ как прогностический фактор злокачественной прогрессии ПВИ // Сборник трудов VIII Всероссийкой научно-практической конференции с международным участием «Молекулярная диагностика ― 2014» / Под ред. В.И. Покровского. Москва, 2014. Т. 1. С. 207. |
| [3] |
Vinogradova OP, Andreeva NA, Epifanova OV. Viral load as a factor of persistence of papillomavirus infection in cervical intraepithelial neoplasia grade I. Ural Medical Journal. 2021;20(4):24–30. (In Russ). doi: 10.52420/2071-5943-2021-20-4-24-30 |
| [4] |
Виноградова О.П., Андреева Н.А., Епифанова О.В. Вирусная нагрузка как фактор персистенции папилломавирусной инфекции при цервикальных интраэпителиальных неоплазиях I степени // Уральский медицинский журнал. 2021. Т. 20, № 4. С. 24–30. doi: 10.52420/2071-5943-2021-20-4-24-30 |
| [5] |
Minkina GN. Cytological screening of the cervical cancer: from the traditional PAP-test to computer technologies. Obstetrics, gynecology and reproduction. 2017;11(1):56–63. (In Russ). doi: 10.17749/2313-7347.2017.11.1.056-063 |
| [6] |
Минкина Г.Н. Цитологический скрининг рака шейки матки: от традиционного пап-теста к компьютерным технологиям // Акушерство, гинекология и репродукция. 2017. T. 11, № 1. С. 56–64. doi: 10.17749/2313-7347.2017.11.1.056-063 |
| [7] |
Savel’eva GM, Sukhikh GT, Serov VN, Radzinskii VE, Manukhin IB, editors. Gynecology. National Leadership. Moscow: GEOTAR-Media; 2017. (In Russ). |
| [8] |
Гинекология. Национальное руководство / под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова, В.Е. Радзинского, И.Б. Манухина. Москва : ГЭОТАР-Медиа, 2017. |
| [9] |
The Russian Society of Specialists in the Prevention and Treatment of tumors of the Reproductive System, the Russian Society of Obstetricians and Gynecologists. Clinical recommendations «Tservikal’naya intraepitelial’naya neoplaziya, eroziya i ektropion sheiki matki». Moscow; 2022. Available from: https://cr.minzdrav.gov.ru/recomend/597_1?ysclid=l9lpzsbsa1510874805. (In Russ). |
| [10] |
Российское общество специалистов по профилактике и лечению опухолей репродуктивной системы, Российское общество акушеров-гинекологов. Клинические рекомендации «Цервикальная интраэпителиальная неоплазия, эрозия и эктропион шейки матки». Москва, 2020. Режим доступа: https://cr.minzdrav.gov.ru/recomend/597_1?ysclid=l9lpzsbsa1510874805. Дата обращения: 23.10.2022. |
| [11] |
Radzinsky VE, Ordiyants IM, Buyanova NV, Zykov EV. Interferon inducers in the combination therapy of uterine cervical diseases in persistent human papillomavirus infection. Obstetrics and Gynecology. 2018;(1):121–126. (In Russ). doi: 10.18565/aig.2018.1.121-126 |
| [12] |
Радзинский В.Е., Ордиянц И.М., Буянова Н.В., Зыков Е.В. Индукторы интерферонов в комплексной терапии заболеваний шейки матки при персистирующей папилломавирусной инфекции // Акушерство и гинекология. 2018. № 1. С. 121–126. doi: 10.18565/aig.2018.1.121-126 |
| [13] |
Protasov AD, Lipatov IS, Kostinov MP, et al. Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up). Urologiia. 2016;(5):47–51. (In Russ). |
| [14] |
Протасов А.Д., Липатов И.С., Костинов М.П., и др. Остроконечные кондиломы аногенитальной области: новый путь решения распространённой проблемы урологии (результаты долгосрочного наблюдения) // Урология. 2016. № 5. С. 47–51. |
| [15] |
Vinogradova OP, Andreeva NA, Artemova OI, Epifanova OV. Cervical Stage II Intraepithelial Neoplasia: Antivirals Efficacy. Doctor.Ru. 2022;21(1):54–58. (In Russ). doi: 10.31550/1727-2378-2022-21-1-54-58 |
| [16] |
Виноградова О.П., Андреева Н.А., Артёмова О.И., Епифанова О.В. Цервикальные интраэпиталиальные неоплазии II степени: эффективность противовирусной терапии // Доктор.Ру. 2022. Т. 21, № 1. С. 54–58. doi: 10.31550/1727-2378-2022-21-1-54-58 |
| [17] |
Zhao J, Guo Z, Wang Q, et al. Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China. Infect Agent Cancer. 2017;12:8. doi: 10.1186/s13027-017-0116-y |
| [18] |
Zhao J., Guo Z, Wang Q., et al. Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China // Infect Agent Cancer. 2017. Vol. 12. P. 8. doi: 10.1186/s13027-017-0116-y |
| [19] |
Artemova OI. Optimizatsiya vedeniya patsientok s patologiyami sheiki matki, assotsiirovannymi s virusom papillomy cheloveka [dissertation]. Samara; 2020. Available from: https://www.samsmu.ru/files/referats/2020/artyomova/dissertation.pdf. (In Russ). |
| [20] |
Артёмова О.И. Оптимизация ведения пациенток с патологиями шейки матки, ассоциированными с вирусом папилломы человека : дис. … канд. мед. наук. Самара, 2020 . Режим доступа: https://www.samsmu.ru/files/referats/2020/artyomova/dissertation.pdf. Дата обращения: 30.10.2022. |
| [21] |
Firichenko SV, Manukhin IB, Rogovskaya SI, Manukhina EI. Pitfalls in cervical screening. Doctor.Ru. 2018;(2):26–34. (In Russ). |
| [22] |
Фириченко С.В., Манухин И.Б., Роговская С.И., Манухина Е.И. «Подводные камни» цервикального скрининга // Доктор.Ру. 2018. № 2 (146). С. 26–34. |
| [23] |
Ershov VA. Neoplazii epiteliya sheiki matki. Saint Petersburg: Chelovek; 2016. 200 p. (In Russ). |
| [24] |
Ершов В.А. Неоплазии эпителия шейки матки. Санкт-Петербург : Человек, 2016. 200 с. |
| [25] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492 |
| [26] |
Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2018. Vol. 68, N 6. P. 394–424. doi: 10.3322/caac.21492 |
| [27] |
Zhang H, Zhang Ya, Zhao H, et al. HPV Infection and Prognostic Factors of Tongue Squamous Cell Carcinoma in Different Ethnic Groups from Geographically Closed Cohort in Xinjiang, China. Biochem Res Int. 2016;2016:7498706. doi: 10.1155/2016/ 7498706 |
| [28] |
Zhang H., Zhang Ya., Zhao H., et al. HPV Infection and Prognostic Factors of Tongue Squamous Cell Carcinoma in Different Ethnic Groups from Geographically Closed Cohort in Xinjiang, China // Biochem Res Int. 2016. Vol. 2016. P. 7498706. doi: 10.1155/2016/ 7498706 |
Vinogradova O.P., Andreeva N.A., Epifanova O.V., Artemova O.I.
/
| 〈 |
|
〉 |